Page 18 - Read Online

Calcif Tissue Int 1999;64:310‑7. cells and collagen gel. Clin Orthop Relat Res 2002;(399):240‑6.
48. Woo BH, Fink BF, Page R, Schrier JA, Jo YW, Jiang G, DeLuca M, 56. Okazaki H, Kurokawa T, Nakamura K, Matsushita T, Mamada K, Kawaguchi H.
Vasconez HC, DeLuca PP. Enhancement of bone growth by sustained delivery Stimulation of bone formation by recombinant fibroblast growth factor‑2 in
of recombinant human bone morphogenetic protein‑2 in a polymeric matrix. callotasis bone lengthening of rabbits. Calcif Tissue Int 1999;64:542‑6.
Pharm Res 2001;18:1747‑53. 57. Wang H, Li X, Tomin E, Doty SB, Lane JM, Carney DH, Ryaby JT. Thrombin
49. Murphy WL, Peters MC, Kohn DH, Mooney DJ. Sustained release of vascular peptide (TP508) promotes fracture repair by up‑regulating inflammatory
endothelial growth factor from mineralized poly (lactide‑co‑glycolide) mediators, early growth factors, and increasing angiogenesis. J Orthop Res
scaffolds for tissue engineering. Biomaterials 2000;21:2521‑7. 2005;23:671‑9.
50. Haidar ZS, Tabrizian M, Hamdy RC. A hybrid rhOP‑1 delivery system enhances 58. Vallet‑Regí M, Ruiz‑González L, Izquierdo‑Barba I. Revisiting silica based
new bone regeneration and consolidation in a rabbit model of distraction ordered mesoporous materials: medical applications. J Mater Chem
osteogenesis. Growth Factors 2010;28:44‑55. 2006;16:26‑31.
51. Konaş E, Emin Mavili M, Korkusuz P, Demir D, Oner F, Canter HI. Acceleration 59. Vallet‑Regí M. Ordered mesoporous materials in the context of drug delivery
of distraction osteogenesis with drug‑releasing distractor. J Craniofac Surg systems and bone tissue engineering. Chemistry 2006;12:5934‑43.
2009;20:2041‑8. 60. Jain RA. The manufacturing techniques of various drug loaded biodegradable
52. Urist MR, Mikulski A, Lietze A. Solubilized and insolubilized bone poly (lactide‑co‑glycolide) (PLGA) devices. Biomaterials 2000;21:2475‑90.
morphogenetic protein. Proc Natl Acad Sci U S A 1979;76:1828‑32. 61. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and
53. Felemovicius J, Ortiz Monasterio F, Gomez Radillo LS, Serna A. Determining PLGA microspheres. Adv Drug Deliv Rev 1997;28:5‑24.
the optimal time for consolidation after distraction osteogenesis. J Craniofac
Surg 2000;11:430‑6.
54. Mofid MM, Inoue N, Atabey A, Marti G, Chao EY, Manson PN, How to cite this article: Singleton AE, Ver Halen JP. Nanotechnology
Vander Kolk CA. Callus stimulation in distraction osteogenesis. Plast Reconstr applications in osteodistraction. Plast Aesthet Res 2014;1:5-12.
Surg 2002;109:1621‑9. Source of Support: Nil, Conflict of Interest: None declared.
55. Takamine Y, Tsuchiya H, Kitakoji T, Kurita K, Ono Y, Ohshima Y, Kitoh H, Received: 21-03-2014; Accepted: 29-05-2014
Ishiguro N, Iwata H. Distraction osteogenesis enhanced by osteoblastlike

12 Plast Aesthet Res || Vol 1 || Issue 1 || Jun 2014